Acadia Pharmaceuticals | ACAD - 销售收入

股票价格

20.23

每天变化

-0.67 -3.21%

每月一次

-16.85%

每年

17.00%

Q1 预测

19.99

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.43B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	销售	更改		日
Acadia Pharmaceuticals	USD 284M		5.4M	2025-12
ALKERMES	USD 384.5M		9.7M	2025-12
Alnylam Pharmaceuticals	USD 1.1B		150M	2025-12
Biogen	USD 2.28B		250M	2025-12
BioMarin Pharmaceutical	USD 875M		99M	2025-12
Bristol-Myers Squibb	USD 12.5B		300M	2025-12
Cara Therapeutics	USD 2.57M		1.11M	2025-03
Corcept Therapeutics	USD 202.12M		5.48M	2025-12
Cytokinetics	USD 17.76M		15.83M	2025-12
Eisai	JPY 219.94B		22.58B	2025-12
Eli Lilly	USD 19.3B		1.7B	2025-12
Incyte	USD 1.51B		140M	2025-12
J&J	USD 24.6B		610M	2025-12
Moderna	USD 678M		342M	2025-12
Neurocrine Biosciences	USD 805.5M		10.6M	2025-12
Pfizer	USD 17.58B		880M	2025-12
Prothena	USD 2.42M		2M	2025-09
PTC Therapeutics	USD 164.7M		46.3M	2025-12
Sarepta Therapeutics	USD 442.9M		43.5M	2025-12
Ultragenyx Pharmaceutical	USD 207M		47M	2025-12
Vanda Pharmaceuticals	USD 198.77M		151.12M	2024-12
Vertex Pharmaceuticals	USD 3.19B		110M	2025-12